Table 2. Significant correlations (p) found between basal mRNA expression and the anthropometric and biochemical variables studied.
| % reduction in weight | % reduction in hip circumference | % reduction in BMI | % reduction in FFA | % reduction in HOMA-IR | ||
| ACC1 | SAT | −0.732 (0.001) | −0.624 (0.033) | −0.731 (0.001) | −0.459 (0.055) | Ns |
| VAT | −0.522 (0.023) | −0.639 (0.010) | −0.576 (0.014) | Ns | Ns | |
| ACSS2 | SAT | −0.521 (0.039) | −0.566 (0.018) | −0.526 (0.052) | −0.519 (0.027) | Ns |
| VAT | −0.623 (0.004) | −0.619 (0.015) | −0.710 (0.001) | Ns | Ns | |
| ACL | SAT | Ns | Ns | Ns | Ns | −0.592 (0.006) |
| VAT | Ns | Ns | Ns | Ns | Ns | |
| PEPCK1 | SAT | −0.529 (0.034) | −0.749 (0.002) | −0.529 (0.049) | Ns | −0.492 (0.038) |
| VAT | Ns | Ns | Ns | Ns | Ns | |
BMI: body mass index; FFA: free fatty acids; HOMA-IR: homeostasis model assessment of insulin resistance index; ACC1: acetyl-coenzyme carboxylase 1; ACSS2: acetyl-CoA synthetase short-chain family member 2; ACL: ATP citrate lyase; PEPCK1: phosphoenolpyruvate carboxykinase 1; SAT: subcutaneous adipose tissue; VAT: visceral adipose tissue; Ns: not significant. Correlation analyses were made with general linear models to adjust by age, gender, and baseline body weight and BMI as independent covariate.